Cheng Chun-Gu, Cheng Chun-An, Chien Wu-Chien, Chung Chi-Hsiang, Lee Jiunn-Tay
Department of Emergency Medicine, Xin Tai General Hospital, New Taipei, Taiwan; Department of Emergency and Critical Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Emergency, Armed Taoyuan General Hospital, Taoyuan, National Defense Medical Center, Taipei, Taiwan.
Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2235-2242. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.007. Epub 2018 May 18.
Endoscopic thoracic sympathectomy (ETS) was performed to cure palmar hyperhidrosis (PH). After ETS, blood pressure decreased, and cerebral flow velocity increased within 1 month. However, no studies distinguish between subsequent ischemic and hemorrhagic stroke following ETS for PH. The association between stroke type and PH after ETS must be evaluated.
We surveyed newly diagnosed patients with PH using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic code 780.8 from the Taiwan Longitudinal National Health Insurance Database. We matched patients with PH who underwent ETS (procedure code 05.29) and without surgery in the database between 2000 and 2010. We defined events as ischemic stroke (ICD-9-CM codes from 433 to 437) or hemorrhagic stroke (ICD-9-CM codes from 430 to 432). Patients were followed up until the first event or December 31, 2010. Risk factors for ischemic stroke and hemorrhagic stroke were analyzed using multivariable Cox proportional hazard regression.
The incidence of ischemic stroke was significantly lower in patients who underwent ETS (.22%) than in patients without surgery (.65%). The patients with PH who received ETS exhibited a reduced risk of ischemic stroke (adjusted hazard ratio [HR] .3; 95% confidence interval [CI] .12-.77). ETS treatment was not associated with a reduction in hemorrhagic stroke (adjusted HR .81; 95% CI .22-3; P = .755).
ETS in patients with PH was associated with reduced subsequent ischemic stroke risk. This additional ischemic stroke preventive effect should encourage health-care supporters to perform ETS in patients with severe PH.
内镜下胸交感神经切除术(ETS)用于治疗手掌多汗症(PH)。ETS术后1个月内血压下降,脑血流速度增加。然而,尚无研究区分ETS治疗PH后随后发生的缺血性和出血性中风。必须评估中风类型与ETS治疗PH后的关联。
我们使用国际疾病分类第九版临床修订本(ICD-9-CM)诊断代码780.8,对台湾纵向全民健康保险数据库中新诊断的PH患者进行了调查。我们在数据库中匹配了2000年至2010年间接受ETS(手术代码05.29)和未接受手术的PH患者。我们将事件定义为缺血性中风(ICD-9-CM代码433至437)或出血性中风(ICD-9-CM代码430至432)。对患者进行随访,直至首次发生事件或2010年12月31日。使用多变量Cox比例风险回归分析缺血性中风和出血性中风的危险因素。
接受ETS的患者缺血性中风发生率(.22%)显著低于未接受手术的患者(.65%)。接受ETS的PH患者发生缺血性中风的风险降低(调整后风险比[HR].3;95%置信区间[CI].12-.77)。ETS治疗与出血性中风风险降低无关(调整后HR.81;95%CI.22-3;P = 0.755)。
PH患者接受ETS与随后缺血性中风风险降低相关。这种额外的缺血性中风预防作用应促使医疗保健支持者对重度PH患者进行ETS治疗。